BioHarvest Sciences (BHST) Cash From Operations

Annual CFO

-$8.52 M
+$719.00 K+7.78%

December 1, 2023

Summary

Performance

1-Year Change

+7.78%

3-Year Change

-119.92%

5-Year Change

-404.86%

15-Year Change

-11736.11%

BHST Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$62.50 K

3-Year Low

-$9.24 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
BHST previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
BHST next annual earnings announcement has not yet been scheduled

OtherBHSTcash flowmetrics:

Annual CFI

-$1.47 M
BHST annual cash flow from investing activities is -$1.47 million

Annual CFF

$13.56 M
BHST annual cash flow from financing activities is $13.56 million

Annual FCF

-$10.00 M
BHST annual free cash flow is -$10.00 million

Annual CAPEX

$1.47 M
BHST annual capital expenditures is $1.47 million

Quarterly CFO

-$1.76 M
-$801.00 K-83.61%

September 1, 2024

Summary

Performance

3-Month Change

-83.61%

1-Year Change

-76.78%

3-Year Change

-23.09%

5-Year Change

-23.09%

BHST Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$15.10 K
BHST quarterly cash flow from operations is currently <-9900.00% below its historical high of $15.10 thousand

3-Year Low

-$2.99 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
BHST previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
BHST next earnings announcement has not yet been scheduled

OtherBHSTcash flowmetrics:

Quarterly CFI

-$472.00 K
BHST quarterly cash flow from investing activities is -$472.00 thousand

Quarterly CFF

-$164.00 K
BHST quarterly cash flow from financing activities is -$164.00 thousand

Quarterly FCF

-$2.27 M
BHST quarterly free cash flow is -$2.27 million

Quarterly CAPEX

$512.00 K
BHST quarterly capital expenditures is $512.00 thousand

TTM CFO

-$7.29 M
-$764.00 K-11.71%

September 1, 2024

Summary

Performance

3-Month Change

-11.71%

1-Year Change

+9.25%

3-Year Change

-26.68%

5-Year Change

-26.68%

BHST TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$22.00 K

3-Year Low

-$9.54 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
BHST previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
BHST next earnings announcement has not yet been scheduled

OtherBHSTcash flowmetrics:

TTM CFI

-$2.92 M
BHST TTM cash flow from investing activities is -$2.92 million

TTM CFF

$11.34 M
BHST TTM cash flow from financing activities is $11.34 million

TTM FCF

-$10.02 M
BHST TTM free cash flow is -$10.02 million

TTM CAPEX

$2.73 M
BHST TTM capital expenditures is $2.73 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BHST Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.8%-76.8%+9.3%
3 y3 years-119.9%-23.1%-26.7%
5 y5 years-404.9%-23.1%-26.7%

BHST Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+25.4%+8.4%+83.6%+70.2%+11.7%+30.8%
5 y5-year+257.6%+8.4%+1641.6%+70.2%+358.1%+30.8%
alltimeall time>+9999.0%+8.4%<-9999.0%+70.2%>+9999.0%+30.8%

BioHarvest Sciences Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.76 M(+83.6%)
-$7.29 M(+11.7%)
Jun 2024
-
-$958.00 K(-39.3%)
-$6.53 M(-22.7%)
Mar 2024
-
-$1.58 M(-47.3%)
-$8.45 M(-0.9%)
Dec 2023
-$8.52 M(-7.8%)
-$2.99 M(+200.9%)
-$8.52 M(+6.1%)
Sep 2023
-
-$995.00 K(-65.4%)
-$8.03 M(-15.8%)
Jun 2023
-
-$2.88 M(+73.9%)
-$9.54 M(+13.6%)
Mar 2023
-
-$1.66 M(-33.9%)
-$8.39 M(-9.2%)
Dec 2022
-$9.24 M(+36.0%)
-$2.50 M(+0.2%)
-$9.24 M(+2.4%)
Sep 2022
-
-$2.50 M(+43.9%)
-$9.02 M(+13.4%)
Jun 2022
-
-$1.74 M(-30.6%)
-$7.95 M(-1.7%)
Mar 2022
-
-$2.50 M(+9.5%)
-$8.09 M(+19.1%)
Dec 2021
-$6.79 M(+75.3%)
-$2.29 M(+60.0%)
-$6.79 M(+18.1%)
Sep 2021
-
-$1.43 M(-23.8%)
-$5.75 M(-7.0%)
Jun 2021
-
-$1.88 M(+55.9%)
-$6.19 M(+40.2%)
Mar 2021
-
-$1.20 M(-3.5%)
-$4.41 M(+13.9%)
Dec 2020
-$3.88 M(+62.6%)
-$1.25 M(-33.1%)
-$3.88 M(+37.6%)
Sep 2020
-
-$1.86 M(+1744.6%)
-$2.82 M(+77.1%)
Jun 2020
-
-$101.00 K(-84.8%)
-$1.59 M(-15.1%)
Mar 2020
-
-$665.00 K(+253.7%)
-$1.88 M(-34.9%)
Jan 2020
-
-$188.00 K(-70.5%)
-$2.88 M(+7.0%)
Dec 2019
-$2.38 M
-
-
Oct 2019
-
-$637.00 K(+65.5%)
-$2.69 M(+32.0%)
DateAnnualQuarterlyTTM
Jul 2019
-
-$385.00 K(-76.9%)
-$2.04 M(+20.7%)
Apr 2019
-$1.69 M(+1128.5%)
-$1.67 M(<-9900.0%)
-$1.69 M(+3020.1%)
Jan 2019
-
$0.00(-100.0%)
-$54.10 K(-39.5%)
Oct 2018
-
$15.10 K(-143.0%)
-$89.40 K(-45.5%)
Jul 2018
-
-$35.10 K(+2.9%)
-$163.90 K(+19.3%)
Apr 2018
-$137.40 K(+90.8%)
-$34.10 K(-3.4%)
-$137.40 K(+16.1%)
Jan 2018
-
-$35.30 K(-40.6%)
-$118.30 K(+20.5%)
Oct 2017
-
-$59.40 K(+590.7%)
-$98.20 K(+98.8%)
Jul 2017
-
-$8600.00(-42.7%)
-$49.40 K(-31.4%)
Apr 2017
-$72.00 K(-45.8%)
-$15.00 K(-1.3%)
-$72.00 K(-11.1%)
Jan 2017
-
-$15.20 K(+43.4%)
-$81.00 K(+8.1%)
Oct 2016
-
-$10.60 K(-66.0%)
-$74.90 K(-49.9%)
Jul 2016
-
-$31.20 K(+30.0%)
-$149.60 K(+12.7%)
Apr 2016
-$132.80 K(+46.6%)
-$24.00 K(+163.7%)
-$132.70 K(+1.5%)
Jan 2016
-
-$9100.00(-89.3%)
-$130.70 K(-9.0%)
Oct 2015
-
-$85.30 K(+496.5%)
-$143.70 K(+73.3%)
Jul 2015
-
-$14.30 K(-35.0%)
-$82.90 K(-8.5%)
Apr 2015
-$90.60 K(+45.0%)
-$22.00 K(-0.5%)
-$90.60 K(+32.1%)
Jan 2015
-
-$22.10 K(-9.8%)
-$68.60 K(+47.5%)
Oct 2014
-
-$24.50 K(+11.4%)
-$46.50 K(+111.4%)
Jul 2014
-
-$22.00 K
-$22.00 K
Apr 2014
-$62.50 K
-
-

FAQ

  • What is BioHarvest Sciences annual cash flow from operations?
  • What is the all time high annual CFO for BioHarvest Sciences?
  • What is BioHarvest Sciences annual CFO year-on-year change?
  • What is BioHarvest Sciences quarterly cash flow from operations?
  • What is the all time high quarterly CFO for BioHarvest Sciences?
  • What is BioHarvest Sciences quarterly CFO year-on-year change?
  • What is BioHarvest Sciences TTM cash flow from operations?
  • What is the all time high TTM CFO for BioHarvest Sciences?
  • What is BioHarvest Sciences TTM CFO year-on-year change?

What is BioHarvest Sciences annual cash flow from operations?

The current annual CFO of BHST is -$8.52 M

What is the all time high annual CFO for BioHarvest Sciences?

BioHarvest Sciences all-time high annual cash flow from operations is -$62.50 K

What is BioHarvest Sciences annual CFO year-on-year change?

Over the past year, BHST annual cash flow from operations has changed by +$719.00 K (+7.78%)

What is BioHarvest Sciences quarterly cash flow from operations?

The current quarterly CFO of BHST is -$1.76 M

What is the all time high quarterly CFO for BioHarvest Sciences?

BioHarvest Sciences all-time high quarterly cash flow from operations is $15.10 K

What is BioHarvest Sciences quarterly CFO year-on-year change?

Over the past year, BHST quarterly cash flow from operations has changed by -$764.00 K (-76.78%)

What is BioHarvest Sciences TTM cash flow from operations?

The current TTM CFO of BHST is -$7.29 M

What is the all time high TTM CFO for BioHarvest Sciences?

BioHarvest Sciences all-time high TTM cash flow from operations is -$22.00 K

What is BioHarvest Sciences TTM CFO year-on-year change?

Over the past year, BHST TTM cash flow from operations has changed by +$743.00 K (+9.25%)